Expression of genes that were decreased below a 1.5-fold cut-off in THP-1 monocytes treated with control medium or cigarette smoke extract for 8 hours. by William R. Wright (182615)

Expression of Clk^DN in photoreceptors leads to genome-wide changes in TF activity and a widespread decrease in chromatin accessibility. by Juan Jauregui-Lozano (12024868)

Population changes of <i>M</i>. <i>bavaricum</i> (a) and cocci (b) in Earth’s field (red symbols), zero field (black symbols) and alternating field (blue symbols) as a function of... by Xuegang Mao (599968)

Subjects:

The m⁶A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells. by Jing Chen (4762)

“…<p>(A) The m⁶A peak marked in green is decreased in the 3’UTR of TLR4, TLR6, MYD88, TRIF, and other 7 genes from m⁶A-seq data in METTL14-knockdown PK-15 cells infected with CSFV (MOI = 1). …”

Supplementary Material for: Optimistic Youth: Young Adults Predicted a Faster Decrease in Risk during COVID-19 Emergency State in Portugal by Scaletti S. (12434691)

“…Our findings suggest that younger adults have a different perception of epidemic-related risk than older adults. …”

Heterologous Immunity Triggered by a Single, Latent Virus in <i>Mus musculus</i>: Combined Costimulation- and Adhesion- Blockade Decrease Rejection by Jonathan M. Beus (441623)

“…<div><p>The mechanisms underlying latent-virus-mediated heterologous immunity, and subsequent transplant rejection, especially in the setting of T cell costimulation blockade, remain undetermined. To address this, we have utilized MHV68 to develop a rodent model of latent virus-induced heterologous alloimmunity. …”

Gibberellic acid in <i>Citrus</i> spp. flowering and fruiting: A systematic review by Alfonso Garmendia (814091)

“…The results on yield were highly erratic as we found increases, decreases, no effects or variable effects.…”

Effect of an olive-oil bioactive extract on basal TEER (A) and TNF-α induced decrease in TEER (B) <i>in vitro</i>. by Martin Liehr (3863431)

Inhibition of VEGF-A gene synthesis decreased ranibizumab and aflibercept mediated CCL2 CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

SDG decreases p70S6K1 and increases AMPK protein expression in iron treated H9c2 cells. by Stephanie Puukila (568109)

The impact of the COVID-19 pandemic on the decrease in the use of intensive care units in the postoperative period of anatomic lung resections. A retrospective analysis by ISMAEL RODRIGO DIAS (12990222)

Growth of cell monolayers and 3D spheroids under different serum concentration in growth media. by Sreerupa Sarkar (9628788)

Subjects:

HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression. by Michael Anthony Ruiz (726055)

“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”

Repeated LSPC treatment prolongs survival of and decreases PrP^Res accumulation in a subset of prion-infected mice. by Heather Bender (363996)

A novel antibiotic-impregnated implant coating results in reduced <i>S. aureus</i> infection, decreased inflammation and prevention of biofilm formation. by Nicholas M. Bernthal (129760)

MiR-133a expression decreases cancer metastasis <i>in vivo</i> and associates with longer survival rates in NSCLC patients. by Lu-Kai Wang (562118)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a dose-dependent manner. by Lan Zhang (90951)

A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes by Sharon Cresci (53599)

“…Consistent with previous descriptions of PPARα in experimental models and human disease, we describe a novel <em>PPARA</em> promoter SNP that decreases transcriptional activation of <em>PPARA</em> and protects against mortality in diabetic patients after ACS.…”

BMP type I receptor antagonists decrease Smad 1/5/8 activity in H1299 cells. by Elaine Langenfeld (402034)